Search Results 1411-1420 of 19402 for hemoglobin

1. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Hemoglobin (Hgb) ≥ 90 g/L,; Platelets (plt) ≥ 100 x 109/L,; Potassium within normal range, or correctable with supplements,; Aspartate Aminotransferase (AST) ...

2. A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL independent of transfusion and/or growth factors within 3 months prior to randomization;; Serum albumin ≥ 3.0 g/dL. Exclusion ...

3. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

   Hemoglobin < 9.0 g/dL; Serum creatinine >1.5 x ULN or calculated or directly measured CrCl < 50% LLN (lower limit of normal); Serum total bilirubin >1.5 x ULN ...

4. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Patients with Solid Tumors - Mayo Clinic

   Absolute neutrophil count (ANC) < 1.5×109/L, platelet count < 100 ×109/L, or hemoglobin < 90 g/L. Serum total bilirubin > 1.5 times the upper limit of ...

5. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

   Hemoglobin ≥ 8 g/dL and independent of transfusion within 7 days of screening. Platelets ≥ 100 x109/L, or ≥ 50 x109/L if bone marrow involvement, and ...

6. Bone marrow transplant - Mayo Clinic

   Learn about this procedure that replaces unhealthy bone marrow with stem cells. Your own cells, donor cells or cells from umbilical cord blood may be used.

7. Innovative Multiple Myeloma Care Renews a Pilot's Energy and Outlook - Mayo Clinic News Network

   My white blood cell count has increased fivefold, and my hemoglobin has doubled,” Harold says. Since Harold's cancer had returned, he had stopped flying. He ...

8. Immune globulin (intramuscular route, intravenous route, subcutaneous route) - Side effects & uses - Mayo Clinic

   It is used for patients who have idiopathic thrombocytopenic purpura (ITP), chronic immune thrombocytopenic purpura, chronic inflammatory demyelinating ...

9. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

   * Hemoglobin \>= 9.0 g/dL (obtained =\< 7 days prior to registration) * Total bilirubin =\< 1.5 x upper limit of normal (ULN) (obtained =\< 7 days prior to ...

10. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    * Hemoglobin level ≤ 9.0 g/dL * Absolute neutrophil count ≤ 1.7 × 109 for subjects who will receive cabazitaxel; \< 1.0 × 109/L for all others * Aspartate ...